NR3C1 and neoplasm: GR can act as both a tumor suppressor and an oncogene, depending on the cancer type or disease stage (Arora et al, 2013; Terwilliger & Abdul‐Hay, 2017; Obradović et al, 2019; Prekovic et al, 2021; Mayayo‐Peralta et al, 2021b).